Latest Equity Financing News

Legacy Minerals has withdrawn its earlier Mt Carrington production targets, updating its Scoping Study to reflect a stronger basis with 71% Indicated Resources. The revised study outlines a 12-year mine life, A$514 million pre-tax NPV7, and a streamlined development plan.

Vanadium Resources (ASX: VR8) has taken major steps to commercialise its Steelpoortdrift project with a non-binding offtake deal with U.S. Vanadium and appointed Rand Merchant Bank to lead funding efforts.

Accelerate Resources (ASX: AX8) has made significant strides in its dual-growth strategy, uncovering multiple gold mineralised corridors at Balagundi and defining a new high-grade manganese hub at Woodie Woodie North during the March 2026 quarter.

Vanadium Resources (ASX: VR8) has signed a non-binding offtake term sheet with U.S. Vanadium for 100% of vanadium slag from its Steelpoortdrift V-Iron Plant, while appointing Rand Merchant Bank to secure project financing.

Minerals 260 has locked in a $220 million funding deal with Franco-Nevada, combining royalty and equity financing to fast-track its 4.5Moz Bullabulling Gold Project. Strong drilling results and accelerated project work underpin a development timeline targeting first production by end 2028.

Radiopharm Theranostics (ASX: RAD) has completed enrolment in its Phase 2b RAD 101 brain metastases imaging trial with interim data showing 90% concordance with MRI, while progressing early-stage trials of therapeutic candidates RAD 202, RV-01, and RAD 402. The company reported a $19.2 million cash balance at quarter end, down from $34.5 million, with a net operating cash outflow of $14.9 million driven by milestone-related R&D and staff costs.

Kalamazoo Resources reported a robust cash balance of AUD 8.8 million at quarter end, underpinned by a significant equity raise that offsets ongoing exploration and administrative outflows. The company’s funding runway extends beyond three quarters, positioning it to advance its Ashburton Gold Project drilling activities.

Tamboran Resources Corporation has initiated an underwritten public offering of nearly 3 million shares to support expanded drilling and resource delineation in the Beetaloo Basin, alongside a concurrent institutional entitlement offer.

Brightstar Resources has successfully upsized its Share Purchase Plan to $18 million, raising total equity proceeds of $193 million to fully fund its Goldfields Project and accelerate development at Sandstone.

GoldArc Resources has locked in a strategic drilling services agreement with MMS for its Leonora South Gold Project, enabling up to A$750,000 of drilling fees to be paid in shares. This innovative deal preserves cash and aligns contractor incentives with the project’s long-term success.

Eden Innovations has taken a major step in strengthening its balance sheet by converting a $2.2 million loan into equity, positioning the company debt free and ready to accelerate growth.

Argenica Therapeutics has reported a significant increase in its half-year loss to $3.82 million, driven by reduced revenue and higher research and development expenses. The company continues to invest heavily in its neuroprotective drug candidate ARG-007 amid ongoing clinical trials.